US 12168767
Modified double-stranded RNA agents
granted A61PA61P43/00
Quick answer
US patent 12168767 (Modified double-stranded RNA agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P43/00